Your browser doesn't support javascript.
loading
Loganin Inhibits Angiotensin II-Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways.
Xu, Jia-Jia; Li, Run-Jing; Zhang, Zheng-Hao; Yang, Cui; Liu, Shi-Xiao; Li, Yan-Ling; Chen, Min-Wei; Wang, Wei-Wei; Zhang, Gong-Ye; Song, Gang; Huang, Zheng-Rong.
Affiliation
  • Xu JJ; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Li RJ; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Zhang ZH; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Yang C; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Liu SX; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Li YL; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Chen MW; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Wang WW; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China.
  • Zhang GY; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China.
  • Song G; Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China.
  • Huang ZR; Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Front Pharmacol ; 12: 678886, 2021.
Article in En | MEDLINE | ID: mdl-34194329

Full text: 1 Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Type: Article Affiliation country: China